These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
156 related items for PubMed ID: 2653513
1. Allogeneic marrow transplantation for acute non-lymphoblastic leukemia: first remission versus after first relapse. Buckner CD, Sanders J, Appelbaum FR. Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():244-6. PubMed ID: 2653513 [No Abstract] [Full Text] [Related]
2. Allogeneic versus autologous bone marrow transplantation versus chemotherapy for treatment of acute myeloid leukemia in first complete remission (BGM 84 and BGMT 87 studies). The BGMT Group. Reiffers J, Stoppa AM, Rigal-Huguet F, Michallet M, Marit G, Gastaut JA, Attal M, Corront B, Broustet A, Hollard D. Bone Marrow Transplant; 1991 Jan; 7 Suppl 2():36. PubMed ID: 1878709 [No Abstract] [Full Text] [Related]
3. Allogeneic and autologous bone marrow transplantation for patients with acute non-lymphoblastic leukemia in first complete remission. The Genoa experience on 119 patients. Carella AM, Piatti G, Frassoni F, Maraone MP, Van Lint MT, Bacigalupo A. Bone Marrow Transplant; 1990 Jul; 6 Suppl 1():55. PubMed ID: 2202469 [No Abstract] [Full Text] [Related]
7. Allogeneic versus autologous bone marrow transplantation versus intensive post-remission chemotherapy in acute leukaemias. Bernasconi C, Lazzarino M, Canevari A, Morra E, Castelli G, Brusamolino E, Alessandrino EP, Pagnucco G, Orlandi E, Castagnola C. Bone Marrow Transplant; 1989 Dec; 4 Suppl 4():65-8. PubMed ID: 2697439 [No Abstract] [Full Text] [Related]
8. Autologous bone marrow transplantation in first remission AML--its relative value. de Gast GC, Zwaan FE, Hagenbeek T, Verdonck LF, Löwenberg B. Bone Marrow Transplant; 1990 Jul; 6 Suppl 1():52-4. PubMed ID: 2202468 [No Abstract] [Full Text] [Related]
9. How do allogeneic bone marrow transplants cure leukaemia? The role of graft versus host disease. Powles R, Treleaven J, Millar J, Gordon-Smith EC, Tiley C, Findlay M, Teo C, Duncombe A, Robinson G. Bone Marrow Transplant; 1991 Jul; 7 Suppl 2():9-10. PubMed ID: 1878737 [No Abstract] [Full Text] [Related]
11. Autologous bone marrow transplantation in patients with AML in second complete remission (CR). Meloni G, De Fabritiis P, Amadori S, Petti MC, Pulsoni A, Sandrelli A, Mandelli F. Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():207-8. PubMed ID: 2653505 [No Abstract] [Full Text] [Related]
12. Autologous bone marrow transplant using 4-HC, VP-16 purged bone marrow for acute non-lymphoblastic leukemia. Gulati SC, Shank B, Sarris A, Berman E, Gee T, Cunningham I, Flomenberg N, O'Reilly RJ, Clarkson B. Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():116-8. PubMed ID: 2653485 [No Abstract] [Full Text] [Related]
13. [Bone marrow transplantation in the treatment of acute leukemias]. Moiseev SI, Ganapiev AA, Abdulkadyrov KM. Ter Arkh; 1996 Jan; 68(12):8-10. PubMed ID: 9054052 [Abstract] [Full Text] [Related]
17. Relative value of allogeneic BMT, autologous BMT and intensive chemotherapy during the first complete remission (CR) of acute myelogenous leukemia (AML). An interim analysis of the AML8 EORTC-GIMEMA protocol. Zittoun R, Mandelli F, De Witte T, Willemze R, Tura S. Bone Marrow Transplant; 1990 Jul; 6 Suppl 1():56-8. PubMed ID: 2202470 [No Abstract] [Full Text] [Related]